论文部分内容阅读
系统性红斑狼疮(SLE),在我国并不少见,病因迄今未明,过去认为本病是一种病情严重,疗效欠佳、死亡率高的疾病。但近年来认为本病发病与免疫有关,特别与抗DNA抗体免疫复合物在各种组织中沉积有关。血浆交换作为免疫抑制剂的一种辅助治疗早已成功地应用在各种与免疫有关的疾病,包括SLE、肺肾综合征(Goodpasture syndrome)、免疫复合物新月形肾炎和免疫性血小板减少症
Systemic lupus erythematosus (SLE), is not uncommon in our country, the etiology has not yet known, in the past that the disease is a serious condition, poor efficacy, high mortality. However, in recent years, the incidence of this disease is considered to be related to immunity, especially related to the deposition of anti-DNA antibody immune complexes in various tissues. An adjuvant therapy of plasma exchange as an immunosuppressive agent has long been successfully used in a variety of immune-related diseases, including SLE, Goodpasture syndrome, immune complex crescentic nephritis and immune thrombocytopenia